https://www.biospace.com/article/releases/curium-announces-first-patients-in-europe-injected-with-pylclari-an-innovative-18f-psma-pet-tracer-indicated-in-patients-with-prostate-cancer-/
0
0
Curium Announces First Patients in Europe Injected With PYLCLARI® – an Innovative 18F-PSMA Pet Tracer Indicated in Patients With Prostate Cancer - BioSpace
11/16/23 at 10:58am
Organization
BioSpace
Author
BioSpace
Details
59 words
Summarize
Health PYLCLARI BioSpace Curium European SYN Innovation Laboratories Curium Announces First Patients PSMA Greece DCFPyL
Curium announced that in partnership with its exclusive distributor SYN Innovation Laboratories in Greece, the first patients in Greece have been injected with PYLCLARI® also known as -DCFPyL, indicated for the detection of prostate-specific membrane antigen …
Create an account or login to join the discussion